199 related articles for article (PubMed ID: 35430257)
41. Natural Products and Extracts as Xantine Oxidase Inhibitors - A Hope for Gout Disease?
Orhan IE; Deniz FSS
Curr Pharm Des; 2021; 27(2):143-158. PubMed ID: 32723252
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and evaluation of xanthine oxidase inhibitory and antioxidant activities of 2-arylbenzo[b]furan derivatives based on salvianolic acid C.
Tang HJ; Zhang XW; Yang L; Li W; Li JH; Wang JX; Chen J
Eur J Med Chem; 2016 Nov; 124():637-648. PubMed ID: 27614410
[TBL] [Abstract][Full Text] [Related]
43. In vivo anti-hyperuricemic and xanthine oxidase inhibitory properties of tuna protein hydrolysates and its isolated fractions.
He W; Su G; Sun-Waterhouse D; Waterhouse GIN; Zhao M; Liu Y
Food Chem; 2019 Jan; 272():453-461. PubMed ID: 30309568
[TBL] [Abstract][Full Text] [Related]
44. Identification and Anti-Hyperuricemic Activity of Xanthine Oxidase Inhibitory Peptides from Pacific White Shrimp and Swimming Crab Based on Molecular Docking Screening.
Mao Z; Jiang H; Mao X
J Agric Food Chem; 2023 Jan; 71(3):1620-1627. PubMed ID: 36625439
[TBL] [Abstract][Full Text] [Related]
45. Antihyperuricemic activity and inhibition mechanism of xanthine oxidase inhibitory peptides derived from whey protein by virtual screening.
Xu Y; Gong H; Zou Y; Mao X
J Dairy Sci; 2024 Apr; 107(4):1877-1886. PubMed ID: 37923199
[TBL] [Abstract][Full Text] [Related]
46. Identification of natural xanthine oxidase inhibitors: Virtual screening, anti-xanthine oxidase activity, and interaction mechanism.
Yu D; Du J; He P; Wang N; Li L; Liu Y; Yang C; Xu H; Li Y
Int J Biol Macromol; 2024 Feb; 259(Pt 2):129286. PubMed ID: 38216015
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, characterization and xanthine oxidase inhibition of Cu(II)-chrysin complex.
Lin S; Zeng L; Zhang G; Liao Y; Gong D
Spectrochim Acta A Mol Biomol Spectrosc; 2017 May; 178():71-78. PubMed ID: 28167361
[TBL] [Abstract][Full Text] [Related]
48. Rapid characterisation of xanthine oxidase inhibitors from the flowers of Chrysanthemum morifolium Ramat. Using metabolomics approach.
Loh KE; Chin YS; Safinar Ismail I; Tan HY
Phytochem Anal; 2022 Jan; 33(1):12-22. PubMed ID: 34000756
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenyl-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives as novel xanthine oxidase inhibitors.
Mao Q; Dai X; Xu G; Su Y; Zhang B; Liu D; Wang S
Eur J Med Chem; 2019 Nov; 181():111558. PubMed ID: 31369933
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and evaluation of 1-hydroxy/methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors.
Chen S; Zhang T; Wang J; Wang F; Niu H; Wu C; Wang S
Eur J Med Chem; 2015 Oct; 103():343-53. PubMed ID: 26363870
[TBL] [Abstract][Full Text] [Related]
51. Discovery and biological evaluation of some (1H-1,2,3-triazol-4-yl)methoxybenzaldehyde derivatives containing an anthraquinone moiety as potent xanthine oxidase inhibitors.
Zhang TJ; Li SY; Yuan WY; Wu QX; Wang L; Yang S; Sun Q; Meng FH
Bioorg Med Chem Lett; 2017 Feb; 27(4):729-732. PubMed ID: 28131711
[TBL] [Abstract][Full Text] [Related]
52. Standardization and xanthine oxidase inhibitory potential of Zanthoxylum armatum fruits.
Ranjana ; Nooreen Z; Bushra U; Jyotshna ; Bawankule DU; Shanker K; Ahmad A; Tandon S
J Ethnopharmacol; 2019 Feb; 230():1-8. PubMed ID: 30342965
[TBL] [Abstract][Full Text] [Related]
53. Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
Šmelcerović A; Tomović K; Šmelcerović Ž; Petronijević Ž; Kocić G; Tomašič T; Jakopin Ž; Anderluh M
Eur J Med Chem; 2017 Jul; 135():491-516. PubMed ID: 28478180
[TBL] [Abstract][Full Text] [Related]
54. Xanthine Oxidase Inhibitory Activity of Euphorbia peplus L. Phenolics.
Kamel EM; Ahmed NA; El-Bassuony AA; Hussein OE; Alrashdi B; Ahmed SA; Lamsabhi AM; Arab HH; Mahmoud AM
Comb Chem High Throughput Screen; 2022; 25(8):1336-1344. PubMed ID: 34151757
[TBL] [Abstract][Full Text] [Related]
55. Effect of luteolin on xanthine oxidase: inhibition kinetics and interaction mechanism merging with docking simulation.
Yan J; Zhang G; Hu Y; Ma Y
Food Chem; 2013 Dec; 141(4):3766-73. PubMed ID: 23993547
[TBL] [Abstract][Full Text] [Related]
56. Xanthine Oxidase Inhibitory and Molecular Docking Studies on Pyrimidones.
Zafar H; Iqbal S; Javaid S; Khan KM; Choudhary MI
Med Chem; 2018; 14(5):524-535. PubMed ID: 29189174
[TBL] [Abstract][Full Text] [Related]
57. Xanthine oxidase inhibitors: patent landscape and clinical development (2015-2020).
Singh JV; Bedi PMS; Singh H; Sharma S
Expert Opin Ther Pat; 2020 Oct; 30(10):769-780. PubMed ID: 32797760
[TBL] [Abstract][Full Text] [Related]
58. Deciphering the inhibitory mechanism of genistein on xanthine oxidase in vitro.
Lin S; Zhang G; Pan J; Gong D
J Photochem Photobiol B; 2015 Dec; 153():463-72. PubMed ID: 26584360
[TBL] [Abstract][Full Text] [Related]
59. Exploring Asphodelus microcarpus as a source of xanthine oxidase inhibitors: Insights from in silico and in vitro studies.
Di Petrillo A; Siguri C; Delogu GL; Fais A; Era B; Floris S; Pintus F; Kumar A; Fantini MC; Olla S
Chem Biol Interact; 2024 Jul; 397():111087. PubMed ID: 38823536
[TBL] [Abstract][Full Text] [Related]
60. An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015).
Ojha R; Singh J; Ojha A; Singh H; Sharma S; Nepali K
Expert Opin Ther Pat; 2017 Mar; 27(3):311-345. PubMed ID: 27841045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
